Evolus (EOLS)
Sells a cosmetic-only neurotoxin and hyaluronic-acid filler line directly to physicians on a cash-pay basis.
$8.17
vs last close+0.18 (+2.25%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 43 days
EPS estimate
−$0.03
Revenue estimate
$77.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.01−$0.18−$0.24−$0.14$0.04−$0.10$0.01Pending
Estimate$0.02−$0.10−$0.09−$0.19$0.06−$0.14−$0.03−$0.03
Surprise−50.0%−80.0%−166.7%+26.3%−26.3%+28.6%+122.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$78.9M$68.1M$69.4M$69.0M$90.3M$73.1M$84.1MPending
Estimate$79.0M$82.3M$85.3M$89.6M$89.5M$72.5M$81.5M$77.9M
Surprise−0.1%−17.3%−18.7%−23.0%+0.9%+0.8%+3.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.22 | — | — |
| Sep 2028 | $0.08 | — | — |
| Jun 2028 | $0.13 | — | — |
| Mar 2028 | $0.05 | — | — |
| Dec 2027 | $0.15 | — | — |
| Sep 2027 | $0.07 | — | — |
| Jun 2027 | $0.07 | — | — |
| Mar 2027 | $0.02 | — | — |
| Dec 2026 | $0.06 | — | — |
| Nov 2026 | −$0.03 | — | — |
| Aug 2026 | −$0.03 | $0.01 | +122.3% |
| May 2026 | −$0.14 | −$0.10 | +28.6% |
| Mar 2026 | $0.06 | $0.04 | −26.3% |
| Nov 2025 | −$0.19 | −$0.14 | +26.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| Apr 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Feb 2018 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.22 | — | — | $135.8M | — | — | — |
| Sep 2028 | $0.08 | — | — | $108.5M | — | — | — |
| Jun 2028 | $0.13 | — | — | $115.7M | — | — | — |
| Mar 2028 | $0.05 | — | — | $100.6M | — | — | — |
| Dec 2027 | $0.15 | — | — | $116.5M | — | — | — |
| Sep 2027 | $0.07 | — | — | $95.4M | — | — | — |
| Jun 2027 | $0.07 | — | — | $97.6M | — | — | — |
| Mar 2027 | $0.02 | — | — | $84.9M | — | — | — |
| Dec 2026 | $0.06 | — | — | $99.0M | — | — | — |
| Nov 4, 2026 | −$0.03 | — | — | $77.9M | — | — | — |
| Aug 5, 2026 | −$0.03 | $0.01 | +122.3% | $81.5M | $84.1M | +3.1% | +19.9% |
| May 4, 2026 | −$0.14 | −$0.10 | +28.6% | $72.5M | $73.1M | +0.8% | +14.2% |
| Mar 3, 2026 | $0.06 | $0.04 | −26.3% | $89.5M | $90.3M | +0.9% | +35.4% |
| Nov 5, 2025 | −$0.19 | −$0.14 | +26.3% | $89.6M | $69.0M | −23.0% | +5.4% |
| Aug 5, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 7, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 24, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 4, 2019 | |||||||
| Aug 12, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Mar 18, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 29, 2018 | |||||||
| Feb 9, 2018 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 |